Company Filing History:
2 out of 655 
1 out of 15,515 
Years Active: 2009
Title: Jin Mo Park: Innovator in Medical Research
Introduction
Jin Mo Park is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of medical research, particularly in the development of innovative methods and compositions for treating serious diseases. With a total of 2 patents, his work has the potential to impact public health significantly.
Latest Patents
Jin Mo Park's latest patents include groundbreaking research on compositions and methods for preventing and treating anthrax diseases. His first patent focuses on compounds and methods for identifying compounds that modulate the interaction of lethal factor and anthrolysin O in the treatment and prevention of anthrax diseases. The second patent involves methods for activating Toll-like receptor 4 via cholesterol-dependent cytolysins isolated from Gram-positive bacteria. This patent also includes compositions containing an isolated cholesterol-dependent cytolysin or a fragment thereof, as well as methods for using such compositions to inhibit the binding and interaction of Toll-like receptor 4 with endotoxin. Furthermore, it outlines methods for identifying modulators of Toll-like receptor 4 activation by a cholesterol-dependent cytolysin and their use in treating septicemia and septic shock.
Career Highlights
Throughout his career, Jin Mo Park has worked with prominent organizations, including the Philadelphia Health and Education Corporation and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Jin Mo Park has collaborated with notable individuals such as Richard F. Rest and Michael Karin. These partnerships have further enhanced his research and innovation in the medical field.
Conclusion
Jin Mo Park is a distinguished inventor whose work in medical research has led to valuable patents aimed at combating serious diseases. His contributions continue to pave the way for advancements in healthcare and treatment methodologies.